243 related articles for article (PubMed ID: 12940925)
1. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
Bonaz B; Boitard J; Marteau P; Lémann M; Coffin B; Flourié B; Belaiche J; Cadiot G; Metman EH; Cortot A; Colombel JF;
Aliment Pharmacol Ther; 2003 Aug; 18(4):401-8. PubMed ID: 12940925
[TBL] [Abstract][Full Text] [Related]
2. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.
Dubinsky MC; Hassard PV; Seidman EG; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
Inflamm Bowel Dis; 2001 Aug; 7(3):181-9. PubMed ID: 11515842
[TBL] [Abstract][Full Text] [Related]
3. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
Almer SH; Hjortswang H; Hindorf U
Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
Belaiche J; Desager JP; Horsmans Y; Louis E
Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
[TBL] [Abstract][Full Text] [Related]
5. Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.
van den Brand FF; van Nieuwkerk CMJ; Verwer BJ; de Boer YS; de Boer NKH; Mulder CJJ; Bloemena E; Bakker CM; Vrolijk JM; Drenth JPH; Tan ACITL; Ter Borg F; Ter Borg MJ; van den Hazel SJ; Inderson A; Tushuizen ME; Bouma G
Aliment Pharmacol Ther; 2018 Oct; 48(7):761-767. PubMed ID: 30109891
[TBL] [Abstract][Full Text] [Related]
6. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
Herrlinger KR; Kreisel W; Schwab M; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Deibert P; Fellermann K; Greinwald R; Stange EF
Aliment Pharmacol Ther; 2003 Feb; 17(4):503-8. PubMed ID: 12622758
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
[TBL] [Abstract][Full Text] [Related]
9. Remission maintenance by tioguanine in chronic active Crohn's disease.
Herrlinger KR; Deibert P; Schwab M; Kreisel W; Fischer C; Fellermann K; Stange EF
Aliment Pharmacol Ther; 2003 Jun; 17(12):1459-64. PubMed ID: 12823147
[TBL] [Abstract][Full Text] [Related]
10. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E; Macdonald JK; Sutherland LR
Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine.
Bastida G; Alvarez-Sotomayor D; Aguas M; Iborra M; Del Hoyo J; Béjar-Serrano S; Garrido-Marín A; Valero-Pérez E; Nos P
Gastroenterol Hepatol; 2024 May; 47(5):473-480. PubMed ID: 38072359
[TBL] [Abstract][Full Text] [Related]
14. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
15. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease.
Lamers CB; Griffioen G; van Hogezand RA; Veenendaal RA
Scand J Gastroenterol Suppl; 1999; 230():111-5. PubMed ID: 10499471
[TBL] [Abstract][Full Text] [Related]
16. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
